The use of chloroquine diphosphate (aralen) and quinacrine (atabrine) hydrochloride in the prevention of polymorphorus light eruptions. (Q41947536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

The use of chloroquine diphosphate (aralen) and quinacrine (atabrine) hydrochloride in the prevention of polymorphorus light eruptions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

M M CAHN

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E J LEVY

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

B SHAFFER

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 1954

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

93-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jid.1954.13

3 November 2019

exact match

0 references

cites work

Treatment of lupus erythematosus with mepacrine

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

Lupus erythematosus treated with mepacrine

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

Atabrine in the treatment of discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

Therapeutic assays of the Skin and Cancer Unit of the New York University Hospital. Assay VII-Quinacrine hydrochloride (atabrine hydrochloride) for chronic discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

Treatment of chronic discoid lupus erythematosus with atabrine

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

The treatment of lupus erythematosus with mepacrine (Atabrine)

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

Quinacrine (atabrine) hydrochloride in treatment of discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

Chloroquine diphosphate in treatment of discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

Treatment of chronic discoid lupus erythematosus with chloroquine (araten).

1 reference

https://api.crossref.org/works/10.1038%2FJID.1954.13

7 January 2021

Identifiers

DOI

10.1038/JID.1954.13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13130891%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference